Company profileNeuroprosthetic
MED-EL
One of the makers of the cochlear implant, the most widely used neural prosthesis.
- Location
- Innsbruck, Austria
- Founded
- 1990
- Class
- NeuroprostheticHearing implants write sound to the auditory nerve. Nothing is decoded from the brain, so it is not counted as a BCI company.Not counted among core BCI companies.
- Website
- medel.com
- Sources last checked
- 7 Oct 2026
What they are building
Innsbruck company founded by Ingeborg and Erwin Hochmair. It makes cochlear implants, auditory brainstem implants, systems that combine electric and acoustic stimulation, and middle-ear and bone-conduction implants.
- Interface category
- Cochlear implants · Auditory brainstem implants
- Signal
- Cochlear: Electrical pulses along an array ordered by pitchABI: Electrical pulses across a paddle of disc electrodes
- Invasiveness
- Invasive
- Recording / stimulation
- Stimulation
- Device
- SYNCHRONY ABI — Implant with a paddle of electrode contacts laid on the cochlear nucleus of the brainstem
- Channels
- 12 contacts
- Regulatory status
- CE marked from 12 months of age, according to the company; its page for clinicians mentions no approval in the United States
- Main use cases
- Hear
Where they are clinically
Approved / cleared
Authorised by a regulator for a defined use. Always check the scope.
Cochlear implants are on the market and are routine care. Most of the studies registered under the company's name concern fitting and outcomes. Its auditory brainstem implant is CE marked, according to the company; its page for clinicians mentions no approval in the United States.
Access today
Available
Authorised and obtainable for a defined group of patients or users.
- Shown in people
- Hearing through an implant in routine care; the registry returns 72 studies under the company's name. In September 2026 it launched in Europe a CE-marked implant with every part under the skin, the microphone included.
- Still an aim
- Approval of that totally implanted system in the United States, where it is not available.
- What stands in the way
- It writes and does not read: nothing about the listener comes back from the implant.
On record here: 0 peer-reviewed papers
Why this company matters
MED-EL is in this directory as a reference point. The cochlear implant is the neural interface that became standard care: routine surgery, reimbursement, decades of follow-up. Every implanted BCI faces questions it has already had to answer, about fitting each user, supporting a device for life and replacing it. It also marks the limit of the comparison: it writes a signal the brain learns to use and reads nothing back.
Key milestones
29 Sep 2026
Company launches TICI UNICO in Europe with a CE mark: a cochlear implant with no external part. It is not approved in the United States.
18 Apr 2018
Company reports a CE mark widened for its auditory brainstem implant: from people aged 15 and over with neurofibromatosis type 2 to people from 12 months of age whose auditory nerve does not work.
1990
Ingeborg and Erwin Hochmair hire the company's first staff in Innsbruck. Their multichannel cochlear implant was first implanted in 1977, according to the company.
Competitive context
CochlearApproved / cleared
Cochlear
Maker of the Nucleus cochlear implant, the most widely used kind of neural prosthesis.
RetinalApproved / cleared
Science Corporation
A retinal implant that restores form vision, now commercially available in Europe.
EEGApproved / cleared
g.tec medical engineering
An Austrian maker of complete BCI systems and of the amplifiers much of the field's research is recorded with, in business since 1999.
Sources
- 01
MED-EL corporate information (opens in a new tab)
Company reportedMED-ELChecked against source 6 Oct 2026
Names the founders and lists the implant types the company makes. It gives no founding year or headcount.
- 02
Meet the woman behind the modern-day cochlear implant: Ingeborg Hochmair (opens in a new tab)
Company reportedMED-ELChecked against source 6 Oct 2026
States that the company hired its first staff in Innsbruck in 1990 and that the founders' multichannel implant was first implanted in 1977.
- 03
Expanded candidacy: auditory brainstem implants (opens in a new tab)
Company reportedMED-EL Professionals Blog18 Apr 2018Checked against source 7 Oct 2026
The company's page for clinicians. Names the SYNCHRONY Auditory Brainstem Implant System and its 12-electrode paddle, and reports a CE mark widened from people aged 15 and over with neurofibromatosis type 2 to people from 12 months of age with a non-functional auditory nerve. It mentions no FDA approval.
- 04
ClinicalTrials.gov: studies naming MED-EL as sponsor or collaborator (opens in a new tab)
Clinical registryClinicalTrials.govChecked against source 6 Oct 2026
72 studies returned for the name on 6 October 2026, under several legal entities.
- 05
MED-EL launches TICI UNICO, a totally implanted cochlear implant (opens in a new tab)
Company reportedMED-EL (press release)29 Sep 2026Checked against source 6 Oct 2026
The company's release: CE mark and launch in Europe; every component, the microphone included, is implanted; not approved by the FDA. We repeat no claim of being first.